The GREACE study emphasizes the urgent need for a wider use of lipid-lowering drugs in high-risk patients. Evaluation (GREACE) Study consisted of patients with coronary heart disease (CHD) followed up for three years1. The patients were randomised to either. Our post-hoc analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study was done to address this issue. Because of the.
|Country:||Saint Kitts and Nevis|
|Published (Last):||3 July 2008|
|PDF File Size:||20.57 Mb|
|ePub File Size:||6.1 Mb|
|Price:||Free* [*Free Regsitration Required]|
This Agreement shall begin on the date hereof. Examples of ‘Non-Financial Competing Interests’ Within the past 4 years, you have held joint grants, published or collaborated with any greacce the authors of the selected paper.
In detail, atorvastatin reduced, in comparison to ‘usual’ care, total mortality RR 0. A summary of the content will be automatically included.
There was a problem providing the content you requested
Please disclose any competing interests that might be construed to influence your judgment of the validity or importance of the article, or any recommendation or review. Grrace patients were followed up for a mean period of 3 years. Long-term statin treatment reduces the frequency of cardiovascular events, but safety and efficacy in patients with abnormal liver tests is unclear. To assess the effect of atorvastatin on morbidity and mortality total and coronary greacd patients with established coronary heart disease CHDconsecutive patients were randomised either to atorvastatin or to ‘usual’ medical care.
I am a Faculty Member who recommended this article. Examples of ‘Financial Competing Interests’ You expect to receive, or in the past 4 years have received, any of the following from any commercial organization that may gain financially from your submission: You may not use stud website for any unlawful purpose, including without limitation, to upload, post, download or otherwise use any Material that you greacr not have the copyright owners permission to so upload, post, download or otherwise use, or that would result in you being in breach of these terms and conditions.
Recommendations Abstract Comments You have reached your article limit. Institutional access Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution.
By clicking “I accept the Terms and Stuudy relating to Materials” before you submit your first Material as hereinafter defined you agree to be bound by these conditions every time you submit Material. Certain parts of this website offer the opportunity for users to post opinions, information and material including without limitation academic papers and data ‘Material’ in areas of the website.
F does not store recipient email addresses. These terms shall be governed by and construed in accordance with English Law.
All subgroups of patients women, those with diabetes mellitus, arterial hypertension, age 60 to 75 years, congestive heart failure, recent unstable angina or prior revascularisation benefited from treatment with atorvastatin. F does not screen, edit, publish or review Material prior to its appearance on the website and is not responsible for it.
Primary endpoints of the study were defined as death, non-fatal myocardial infarction, unstable angina, congestive heart failure, revascularisation coronary morbidity and stroke. Material does not reflect the views or opinions of F, its agents or affiliates.
This entry form currently does not support special characters. Consider the following examples, but note that this is not an exhaustive list: You are entitled to post or upload the Material on the website and have all necessary licenses and consents to do so; the Material does not infringe any intellectual property right, including without limitation copyright, patent or trademark, or other proprietary right of any third party; the Material does not contain any defamatory, libellous, offensive, indecent or otherwise unlawful material or material which is an invasion of privacy; the Material does not contain any contaminating or destructive features or devices such as viruses, time bombs or coding designed to interrupt, destroy or limit the functionality of this website or any of this website’s user’s computer equipment or software; the Material will not be used to solicit or promote business or custom or present commercial activities or unlawful activity; and the Material is in compliance with all applicable laws.
Recommend to your librarian. F reserves the right to monitor all Material and to remove any Material which it considers in its absolute discretion to be unlawful, inappropriate, offensive or otherwise in breach of these Terms and Conditions. By posting Material you grant to F an irrevocable non-exclusive royalty-free license to keep a copy of Material for a reasonable period and as necessary to enable it to comply with its legal obligations.
Disclosures Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. However, there is no long-term survival study that evaluated this statin. You hereby agree to indemnify and keep indemnified F, its affiliates, contractors and agents from and against any and all losses including without limitation direct, indirect and consequential losscosts, claims, damages or expenses of whatever nature and howsoever caused arising directly or indirectly from any breach of these Terms and Conditions or arising from the Material posted on this website or content contained in any email sent using the facilities provided by the website by you including without limitation as a result of any infringement of any intellectual property or other proprietary rights, libel, defamation, obscenity or the Material being otherwise unlawful.
I am an author of this article. Don’t have an account? FPrime is an expert-curated resource to help you find the articles of greatest interest and relevance to you. I would like to receive updates when further comments, recommendations, or dissenting opinions are publishing on this article.
You are an Editor for the journal in which the article is published. Statin treatment is safe and can improve liver tests and reduce cardiovascular morbidity in patients with mild-to-moderately abnormal liver tests that are potentially attributable to non-alcoholic fatty liver disease. Register for day free trial Registration is free and only takes a moment, or subscribe for unlimited access.
User comments must be in English, comprehensible and relevant to the article under discussion. Comment in Curr Med Res Opin. Treatment with atorvastatin is well tolerated yreace cost-effective. Any view or opinion expressed in any Material is the view or opinion of the person who posts such view or opinion.
By posting or uploading Material you warrant and represent that: You have a close personal relationship e. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Neither of the above.
GREACE (GREek Atorvastatin Coronary-heart-disease Evaluation) study – General Practice Notebook
F reserves the right to remove any comments that it considers in its absolute discretion to be inappropriate, offensive or otherwise grreace breach of the Terms and Conditions relating to Materials including Comments.
Long-term treatment of CHD patients with atorvastatin to achieve NCEP lipid targets significantly reduces total and coronary mortality, coronary morbidity and stroke, in comparison to patients receiving ‘usual’ medical care. The use of certain tools provided by this website is subject to additional Terms and Conditions. Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution.
Secondary endpoints were the safety and efficacy of the hypolipidaemic drugs as well as the cost-effectiveness of atorvastatin.
You work at the same institute as any of the authors. Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol LDL-C levels. Accordingly you may only post Material that you have the right to do so.